Bradley H. Thomas

Array ( [id] => 20486160 [patent_doc_number] => 20260022358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-22 [patent_title] => Compositions and Methods for Kallikrein (KLKB1) Gene Editing [patent_app_type] => utility [patent_app_number] => 19/331096 [patent_app_country] => US [patent_app_date] => 2025-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19331096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20542432 [patent_doc_number] => 20260049322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-19 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 19/307810 [patent_app_country] => US [patent_app_date] => 2025-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19307810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20453280 [patent_doc_number] => 12516332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Composition for regulating production of interfering ribonucleic acid [patent_app_type] => utility [patent_app_number] => 19/194480 [patent_app_country] => US [patent_app_date] => 2025-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 389 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19194480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179772 [patent_doc_number] => 20250263730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 19/194571 [patent_app_country] => US [patent_app_date] => 2025-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19194571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179836 [patent_doc_number] => 20250263794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => RNA AND DNA ANALYSIS USING ENGINEERED SURFACES [patent_app_type] => utility [patent_app_number] => 19/184759 [patent_app_country] => US [patent_app_date] => 2025-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30428 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19184759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20295209 [patent_doc_number] => 20250320452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => MICROORGANISMS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/092488 [patent_app_country] => US [patent_app_date] => 2025-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19092488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20372683 [patent_doc_number] => 12480109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Compositions and methods for kallikrein (KLKB1) gene editing [patent_app_type] => utility [patent_app_number] => 19/028692 [patent_app_country] => US [patent_app_date] => 2025-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 53 [patent_no_of_words] => 52161 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20068911 [patent_doc_number] => 20250207133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE [patent_app_type] => utility [patent_app_number] => 18/999652 [patent_app_country] => US [patent_app_date] => 2024-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18999652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20025214 [patent_doc_number] => 20250163436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/933750 [patent_app_country] => US [patent_app_date] => 2024-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20025213 [patent_doc_number] => 20250163435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/933645 [patent_app_country] => US [patent_app_date] => 2024-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20025212 [patent_doc_number] => 20250163434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/933567 [patent_app_country] => US [patent_app_date] => 2024-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20357568 [patent_doc_number] => 12473555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Composition for regulating production of interfering ribonucleic acid [patent_app_type] => utility [patent_app_number] => 18/933499 [patent_app_country] => US [patent_app_date] => 2024-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 420 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19904313 [patent_doc_number] => 12281309 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-22 [patent_title] => Composition for regulating production of interfering ribonucleic acid [patent_app_type] => utility [patent_app_number] => 18/889137 [patent_app_country] => US [patent_app_date] => 2024-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18889137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19840319 [patent_doc_number] => 12252691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-18 [patent_title] => Compositions and methods for inhibiting LPA expression [patent_app_type] => utility [patent_app_number] => 18/807591 [patent_app_country] => US [patent_app_date] => 2024-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 31987 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18807591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19601411 [patent_doc_number] => 20240392291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => NUCLEOTIDE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/769446 [patent_app_country] => US [patent_app_date] => 2024-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18769446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20527514 [patent_doc_number] => 12545941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-10 [patent_title] => MGAT1 deficient cells and uses thereof [patent_app_type] => utility [patent_app_number] => 18/665736 [patent_app_country] => US [patent_app_date] => 2024-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 2930 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19543410 [patent_doc_number] => 20240360446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => MICRORNA-29 COMPOUNDS, COMPOSITIONS AND USES IN THERAPY, AND METHODS FOR EVALUATING TENDINOPATHIC LESIONS [patent_app_type] => utility [patent_app_number] => 18/648316 [patent_app_country] => US [patent_app_date] => 2024-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18648316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19281892 [patent_doc_number] => 20240218366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/586689 [patent_app_country] => US [patent_app_date] => 2024-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19332831 [patent_doc_number] => 20240247261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => miRNA Switches for RNA-Triggered Control of RNA Interference [patent_app_type] => utility [patent_app_number] => 18/393408 [patent_app_country] => US [patent_app_date] => 2023-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18393408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20025210 [patent_doc_number] => 20250163432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/518177 [patent_app_country] => US [patent_app_date] => 2023-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518177 [rel_patent_id] =>[rel_patent_doc_number] =>)